A Sleep Program to Improve Sleep Quality in People With HIV
Efficacy Potential of an Internet-based Sleep Program to Improve Sleep Quality in People With HIV
2 other identifiers
interventional
27
1 country
1
Brief Summary
Sleep problems, such as insomnia, are more frequent and intense in individuals living with HIV. These sleep difficulties can increase the difficulties in thinking and concentrating. Digital cognitive behavioral therapy for insomnia (dCBT-I) is a computer-based treatment intervention that provides strategies to improve sleep. This intervention has been shown to improve sleep and daytime function (concentration, productivity) in people with insomnia. However, the effects of this intervention in people living with HIV are unknown.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 25, 2015
CompletedFirst Posted
Study publicly available on registry
October 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2020
CompletedAugust 12, 2020
August 1, 2020
5.3 years
August 25, 2015
August 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ratio of total sleep time over time in bed
Obtained from the online self-reported sleep diaries aggregated over 7 days, completed at study entry and again at 12 weeks
12 weeks
Secondary Outcomes (5)
Insomnia Severity as assessed by the Insomnia Severity Index
12 weeks
Cognitive performance as assessed by the Brief Cognitive Ability Measure (B-CAM)
9 months
Anxiety and Depression symptoms as assessed by the Hospital Anxiety Depression Scale
9 months
Quality of life as assessed by the WHO-QOL-HIV
9 months
Quality of life as assessed by the EQ-5D
9 months
Study Arms (2)
Immediate dCBT-I group
EXPERIMENTALDigital cognitive behavioural therapy for insomnia (dCBT-I) is a 6 session training program (spanning 6 to 12 weeks) designed to improve sleep. Participants in the immediate dCBT-I group will receive the Sleepio intervention shortly after enrollment.
Waitlist control group
EXPERIMENTALParticipants in the waitlist control group will receive sleep hygiene recommendations from validated online resources for HIV patients (http://www.catie.ca/en/positiveside/winter-2013/sleep-tight) around the time of enrollment. They will start the digital cognitive behavioural therapy for insomnia (dCBT-I) intervention 12-14 weeks after the initial enrollment.
Interventions
dCBT-I is a computer-based treatment intervention that provides strategies to improve sleep and daytime function (concentration, productivity) in individuals with insomnia
Eligibility Criteria
You may qualify if:
- Evidence of insomnia disorder (Sleep Condition Indicator \[SCI\] ≤ 16)
- Able to have convenient weekly access to the Internet
- Stable medical condition
- Have been on a stable HAART regimen for \> 6 months
- Have not had a change in medications that could potentially interfere with sleep or cognition in the past 4 months.
You may not qualify if:
- Berlin questionnaire score indicating high risk of obstructive sleep apnea
- Known history of sleep disorders (e.g., narcolepsy, hypersomnia, restless legs syndrome, REM-sleep behavior disorder) which currently require or previously required treatment
- Ongoing involvement in night shift work
- Not able to complete the 12 weeks of the sleep intervention due to a scheduling conflict
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- McGill Universitylead
- Sleepiocollaborator
Study Sites (1)
Montreal Neurological Institute and Hospital (McGill University)
Montreal, Quebec, H3A 2B4, Canada
Related Publications (25)
Norman SE, Chediak AD, Kiel M, Cohn MA. Sleep disturbances in HIV-infected homosexual men. AIDS. 1990 Aug;4(8):775-81. doi: 10.1097/00002030-199008000-00009.
PMID: 2261133BACKGROUNDRubinstein ML, Selwyn PA. High prevalence of insomnia in an outpatient population with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Nov 1;19(3):260-5. doi: 10.1097/00042560-199811010-00008.
PMID: 9803968BACKGROUNDJean-Louis G, Weber KM, Aouizerat BE, Levine AM, Maki PM, Liu C, Anastos KM, Milam J, Althoff KN, Wilson TE. Insomnia symptoms and HIV infection among participants in the Women's Interagency HIV Study. Sleep. 2012 Jan 1;35(1):131-7. doi: 10.5665/sleep.1602.
PMID: 22215927BACKGROUNDLow Y, Goforth HW, Omonuwa T, Preud'homme X, Edinger J, Krystal A. Comparison of polysomnographic data in age-, sex- and Axis I psychiatric diagnosis matched HIV-seropositive and HIV-seronegative insomnia patients. Clin Neurophysiol. 2012 Dec;123(12):2402-5. doi: 10.1016/j.clinph.2012.05.004. Epub 2012 Jun 23.
PMID: 22727712BACKGROUNDCruess DG, Antoni MH, Gonzalez J, Fletcher MA, Klimas N, Duran R, Ironson G, Schneiderman N. Sleep disturbance mediates the association between psychological distress and immune status among HIV-positive men and women on combination antiretroviral therapy. J Psychosom Res. 2003 Mar;54(3):185-9. doi: 10.1016/s0022-3999(02)00501-9.
PMID: 12614827BACKGROUNDBabson KA, Heinz AJ, Bonn-Miller MO. HIV medication adherence and HIV symptom severity: the roles of sleep quality and memory. AIDS Patient Care STDS. 2013 Oct;27(10):544-52. doi: 10.1089/apc.2013.0221. Epub 2013 Sep 13.
PMID: 24032625BACKGROUNDGamaldo CE, Gamaldo A, Creighton J, Salas RE, Selnes OA, David PM, Mbeo G, Parker BS, Brown A, McArthur JC, Smith MT. Evaluating sleep and cognition in HIV. J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):609-16. doi: 10.1097/QAI.0b013e31829d63ab.
PMID: 23722610BACKGROUNDHudson AL, Portillo CJ, Lee KA. Sleep disturbances in women with HIV or AIDS: efficacy of a tailored sleep promotion intervention. Nurs Res. 2008 Sep-Oct;57(5):360-6. doi: 10.1097/01.NNR.0000313501.84604.2c.
PMID: 18794720BACKGROUNDWebel AR, Moore SM, Hanson JE, Patel SR, Schmotzer B, Salata RA. Improving sleep hygiene behavior in adults living with HIV/AIDS: a randomized control pilot study of the SystemCHANGE(TM)-HIV intervention. Appl Nurs Res. 2013 May;26(2):85-91. doi: 10.1016/j.apnr.2012.10.002. Epub 2012 Dec 21.
PMID: 23265919BACKGROUNDMorin CM. Cognitive-behavioral approaches to the treatment of insomnia. J Clin Psychiatry. 2004;65 Suppl 16:33-40.
PMID: 15575803BACKGROUNDMorin CM, Hauri PJ, Espie CA, Spielman AJ, Buysse DJ, Bootzin RR. Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review. Sleep. 1999 Dec 15;22(8):1134-56. doi: 10.1093/sleep/22.8.1134.
PMID: 10617176BACKGROUNDMorin CM, Vallieres A, Guay B, Ivers H, Savard J, Merette C, Bastien C, Baillargeon L. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009 May 20;301(19):2005-15. doi: 10.1001/jama.2009.682.
PMID: 19454639BACKGROUNDRiemann D, Perlis ML. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev. 2009 Jun;13(3):205-14. doi: 10.1016/j.smrv.2008.06.001. Epub 2009 Feb 7.
PMID: 19201632BACKGROUNDMorin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA. 1999 Mar 17;281(11):991-9. doi: 10.1001/jama.281.11.991.
PMID: 10086433BACKGROUNDManber R, Edinger JD, Gress JL, San Pedro-Salcedo MG, Kuo TF, Kalista T. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008 Apr;31(4):489-95. doi: 10.1093/sleep/31.4.489.
PMID: 18457236BACKGROUNDSavard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. J Clin Oncol. 2005 Sep 1;23(25):6083-96. doi: 10.1200/JCO.2005.09.548.
PMID: 16135475BACKGROUNDLancee J, van den Bout J, van Straten A, Spoormaker VI. Internet-delivered or mailed self-help treatment for insomnia?: a randomized waiting-list controlled trial. Behav Res Ther. 2012 Jan;50(1):22-9. doi: 10.1016/j.brat.2011.09.012. Epub 2011 Oct 24.
PMID: 22055281BACKGROUNDEspie CA, Kyle SD, Williams C, Ong JC, Douglas NJ, Hames P, Brown JS. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep. 2012 Jun 1;35(6):769-81. doi: 10.5665/sleep.1872.
PMID: 22654196BACKGROUNDEspie CA, Inglis SJ, Harvey L. Predicting clinically significant response to cognitive behavior therapy for chronic insomnia in general medical practice: analysis of outcome data at 12 months posttreatment. J Consult Clin Psychol. 2001 Feb;69(1):58-66. doi: 10.1037//0022-006x.69.1.58.
PMID: 11302278BACKGROUNDEspie CA, MacMahon KM, Kelly HL, Broomfield NM, Douglas NJ, Engleman HM, McKinstry B, Morin CM, Walker A, Wilson P. Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep. 2007 May;30(5):574-84. doi: 10.1093/sleep/30.5.574.
PMID: 17552372BACKGROUNDEspie CA, Fleming L, Cassidy J, Samuel L, Taylor LM, White CA, Douglas NJ, Engleman HM, Kelly HL, Paul J. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol. 2008 Oct 1;26(28):4651-8. doi: 10.1200/JCO.2007.13.9006. Epub 2008 Jun 30.
PMID: 18591549BACKGROUNDKyle SD, Miller CB, Rogers Z, Siriwardena AN, Macmahon KM, Espie CA. Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder. Sleep. 2014 Feb 1;37(2):229-37. doi: 10.5665/sleep.3386.
PMID: 24497651BACKGROUNDEspie CA, Kyle SD, Hames P, Gardani M, Fleming L, Cape J. The Sleep Condition Indicator: a clinical screening tool to evaluate insomnia disorder. BMJ Open. 2014 Mar 18;4(3):e004183. doi: 10.1136/bmjopen-2013-004183.
PMID: 24643168BACKGROUNDBastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001 Jul;2(4):297-307. doi: 10.1016/s1389-9457(00)00065-4.
PMID: 11438246BACKGROUNDMayo NE, Brouillette MJ, Fellows LK; Positive Brain Health Now Investigators. Understanding and optimizing brain health in HIV now: protocol for a longitudinal cohort study with multiple randomized controlled trials. BMC Neurol. 2016 Jan 14;16:8. doi: 10.1186/s12883-016-0527-1.
PMID: 26762403DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lesley K Fellows, MD, DPhil
McGill University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Neurologist
Study Record Dates
First Submitted
August 25, 2015
First Posted
October 8, 2015
Study Start
May 1, 2015
Primary Completion
August 1, 2020
Study Completion
August 1, 2020
Last Updated
August 12, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will share
Fully anonymized individual data may be requested from the investigators.